Zepbound (tirzepatide) has emerged as a leading once-weekly injectable treatment for chronic weight management, offering dual-action benefits through its activation of both GLP-1 and GIP receptors. This innovative mechanism suppresses appetite, enhances satiety, slows gastric emptying, and improves metabolic function, resulting in substantial and sustained weight reduction when combined with a reduced-calorie diet and increased […]